Originally posted on invasivecardiology: Stefan Toggweiler, MD Evidence indicates that postprocedural moderate or severe paravalvular regurgitation (PAR) reduces life expectancy in such a way that it may even nullify the beneficial effect of TAVI. Due to improved implantation techniques, knowledge, and materials, the rates of moderate or severe PAR have dropped to less than 5%-10%…

Originally posted on invasivecardiology: By Atman P. Shah, MD, FACC, FSCAI Clinical Director, Section of Cardiology Co-Director, Cardiac Catheterization Laboratory Associate Professor of Medicine The University of Chicago Interventional cardiologists are increasingly able to take care of complex coronary artery disease in a population of patients that would have be been deemed too high-risk a…